Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that significantly impacts cogn...
Vascular cognitive impairment (VCI) is an umbrella term for diseases associated with cognitive decli...
The current depth of site-specific N-glycoproteomics is insufficient to fully characterize glycosyla...
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), ...
This study developed machine learning models to predict Aβ positivity in Alzheimer's disease by inte...
This paper introduces supervised learning techniques for real-time selection (triggering) of hadroni...
Tumor suppressor genes (TSGs) are critical regulators of cellular homeostasis and are extensively st...
Extracellular vesicles (EVs) in plasma are composed of exosomes, microvesicles, and apoptotic bodies...
Alzheimer's Disease (AD) poses a significant global health challenge, necessitating early and accura...
BackgroundArtificial Intelligence (AI) is increasingly integrated into healthcare systems, presentin...
BackgroundMild cognitive impairment (MCI) is a risk factor for dementia, and early screening is cruc...
BackgroundThe retrogenesis hypothesis (RH) suggests that the functional and cognitive decline observ...
BACKGROUND: The connection between cognition, eye, and brain remains inconclusive in Alzheimer's dis...
BACKGROUND AND OBJECTIVES: Distinguishing neurodegenerative diseases is a challenging task requiring...
BackgroundDistinct risk factors influence Alzheimer's disease (AD) stage stratification, yet effecti...
OBJECTIVE: Electroencephalography (EEG) is a method that offers detailed observations of electrical ...
BACKGROUND AND PURPOSE: Identifying amyloid-beta (Aβ)-positive patients is essential for Alzheimer's...
Dysregulation of lipid metabolism is increasingly recognized as a key factor in the pathogenesis of ...
γ neuromodulation has emerged as a promising strategy for addressing neurological and psychiatric di...
BACKGROUND: Two of the most common complaints seen in neurology clinics are Alzheimer's disease (AD)...
The PET Imaging Site Qualification Program for amyloid positron emission tomography (PET) in Japan i...